Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for the treatment of type 2 diabetes and long-term weight management. It works by mimicking the intestinal hormone GLP-1 through mechanisms that include: stimulating insulin secretion to lower blood glucose; delaying gastric emptying, increasing satiety, and suppressing appetite to aid weight loss. Semaglutide is typically administered as a once-weekly subcutaneous injection.
Product advantages:
1.Powerful hypoglycemic effect: Significantly reduces HbA1c (up to 1.5%-2.0%).
2.Weight management: Average weight loss of 10%-15% (clinical trial data).
3.Cardiovascular benefits: Reduce the risk of major cardiovascular events (such as myocardial infarction and stroke) in patients with type 2 diabetes.
Product Display
Analysis Report
Customer Feedback
Shipping
